U.S. regulators have approved the first blood test to help diagnose Alzheimer’s disease, potentially making it easier to find ...

The Food and Drug Administration (FDA) has cleared Lumipulse G for U.S. commercialization as the first blood-based test that ...

The US Food and Drug Administration (FDA) has approved the first-ever blood test to diagnose the debilitating Alzheimer's disease early.

US regulators have approved the first blood test to help diagnose Alzheimer’s disease, potentially making it easier to find ...

(Bloomberg) -- US regulators have approved the first blood test to help diagnose Alzheimer’s disease, potentially making it ...

The Lumipulse Alzheimer's blood test is the first of a new generation of tests that may replace brain scans and spinal taps to detect the disease.

Other options to detect Alzheimer's include procedures such as a spinal tap, which requires an invasive puncture to collect ...

The FDA has approved the first blood test for diagnosing Alzheimer’s disease, which could speed the path to treatment for ...

The FDA said it has issued its first official green light for a blood test to help diagnose Alzheimer’s disease, adding that ...

The FDA has cleared Fujirebio Diagnostics' Lumipulse blood test, marking the first of its kind for Alzheimer's diagnosis.

BioArctic AB's (publ) (Nasdaq Stockholm: BIOA B) partner Eisai today announced that Leqembi sales are expected to total JPY 76.5 billion (approximately SEK 5.1 billion) for their fiscal year (FY) 2025 ...